Federal budget legislation passed last month did so without the inclusion of the Cole-Bishop Amendment, which would have eased the impending threat to the vapor product industry posed by the regulatory framework outlined by the U.S. Food and Drug Administration (FDA).
The Cole-Bishop Amendment was originally included in the bill and had been sponsored by U.S. Representatives Tom Cole (R-OK) and Sanford Bishop (D-GA) who introduced it back in April.
If passed, the amendment would have moved the predicate, or “grandfather date” from Feb. 15, 2007 to sometime in 2016, which would have granted the majority of vapor products on the market an easier path for approval by the FDA.
Lawmakers in Congress are in support of the vaping industry, according to Gregory Conley, president of the American Vaping Association (AVA), who told CSP Daily News that whatever version the amendment will newly emerge as will have a chance to pass in the spring.
“With the new [President-elect] Trump administration, we’re hoping to pull the FDA before Congress [on this matter],” Conley said.
To read the CSP Daily News article, click here.